Trial Profile
Atosiban Versus Placebo in the Treatment of Late Threatened Preterm Birth
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2023
Price :
$35
*
At a glance
- Drugs Atosiban (Primary)
- Indications Preterm labour
- Focus Adverse reactions
- Acronyms APOSTEL VIII
- 19 Jan 2019 Planned number of patients changed from 1598 to 1514.
- 21 Jul 2017 New trial record